(Q64662356)
Statements
A Phase 3 Randomized, Double-Blind, Placebo- And Oxycodone-Controlled, Multicenter Study Of The Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee Or Hip (English)
0 references
October 2009
0 references
December 2010
0 references
600
0 references
18 year
0 references
75 year
0 references